REGULATORY

• Sumitomo to Urge Switch from Noritren over Carcinogen Risks, but Continues Shipments
  June 8, 2023

• LDP Lawmakers Oppose Online Sale of Morning After Pills 3 Years after Switch
  June 8, 2023

• LDP League Submits Proposal to Ensure Stable Generic Supplies
  June 8, 2023

• Draft Honebuto Paper Unveiled, Cabinet OK Expected in Mid-June
  June 8, 2023

• Expert Panel Broadly OKs Draft Report on Pharma Policies, Further Deliberations by Other Forums
  June 7, 2023

• Draft Honebuto Paper Calls for Further Drug Pricing Measures to Reward Innovation
  June 7, 2023

• Japan Unveils Healthcare DX Timeline, Set to Drive Secondary Data Usage by Drug Makers
  June 6, 2023

• Japan Likely to Approve Its 1st Cold Meds Containing Loxoprofen
  June 6, 2023

• LDP Project Team Submits Proposal to Prime Minister
  June 5, 2023

• Expert Panel to Propose Setting Up Requirements for Generic Entry to Ensure Stable Supplies; Draft Report Due Out June 6
  June 5, 2023

• Expert Panel Wants to See Action on Excessive Yakkasa, No Direction on Buffer Zone: Draft Report
  June 5, 2023

• Expert Panel Pushes Fresh Evaluation Approach for New Drug Pricing, Rethink of Spillovers: Draft Report
  June 5, 2023

• Ferring’s Oral Budesonide for UC Passes Advisor Review for Approval
  June 5, 2023

• Deregulation Panel Urges Discussions on Secondary Use of Medical Data Without Patient Consent
  June 2, 2023

• Public Knowledge-Based Application OK’ed for Endoxan Label Expansion
  June 2, 2023

• SaMD Could Be Eligible for 2-Stage Approval System: MHLW
  June 1, 2023

• Japan Diet Enacts Bill to Create “Japan CDC”
  June 1, 2023

• Japan to Quadruple Supplies of Sublingual Hay Fever Therapy in 5 Years
  May 31, 2023

• LDP OKs Project Team Proposal to Boost Pharma Innovation, Create Command Tower
  May 31, 2023

• LDP Launches Lawmakers’ League on Self-Medication
  May 31, 2023

ページ

• « 先頭
• ‹ Prev
• …
• 83
• 84
• 85
• 86
• 87
• 88
• 89
• 90
• 91
• …
• Next ›
• 最終 »